DK175773B1 - Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler - Google Patents

Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler Download PDF

Info

Publication number
DK175773B1
DK175773B1 DK199200300A DK30092A DK175773B1 DK 175773 B1 DK175773 B1 DK 175773B1 DK 199200300 A DK199200300 A DK 199200300A DK 30092 A DK30092 A DK 30092A DK 175773 B1 DK175773 B1 DK 175773B1
Authority
DK
Denmark
Prior art keywords
drug
patient
dose
matrix
mouth
Prior art date
Application number
DK199200300A
Other languages
Danish (da)
English (en)
Other versions
DK30092D0 (da
DK30092A (da
Inventor
Brian Hague
Theodore H Stanley
Original Assignee
Univ Utah Res Foundation Unive
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Foundation Unive filed Critical Univ Utah Res Foundation Unive
Publication of DK30092D0 publication Critical patent/DK30092D0/da
Publication of DK30092A publication Critical patent/DK30092A/da
Application granted granted Critical
Publication of DK175773B1 publication Critical patent/DK175773B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK199200300A 1989-09-05 1992-03-05 Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler DK175773B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1989/003801 WO1991003233A1 (en) 1989-09-05 1989-09-05 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
US8903801 1989-09-05

Publications (3)

Publication Number Publication Date
DK30092D0 DK30092D0 (da) 1992-03-05
DK30092A DK30092A (da) 1992-05-05
DK175773B1 true DK175773B1 (da) 2005-02-14

Family

ID=22215208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199200300A DK175773B1 (da) 1989-09-05 1992-03-05 Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler

Country Status (8)

Country Link
EP (1) EP0493380B1 (de)
JP (1) JP2758985B2 (de)
AT (1) ATE159658T1 (de)
AU (2) AU645966B2 (de)
DE (1) DE68928415T2 (de)
DK (1) DK175773B1 (de)
NO (2) NO920854L (de)
WO (1) WO1991003233A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155036B (da) * 1977-08-05 1989-01-30 Battelle Memorial Institute Fremgangsmaade til fremstilling af oploesninger eller suspensioner af liposomer i vandige medier.

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0745380B1 (de) * 1995-05-11 2005-08-03 University Of Utah Research Foundation Tabakersatz
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
US7776831B2 (en) * 2006-02-01 2010-08-17 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
US20160022643A1 (en) * 2014-07-22 2016-01-28 Professional Compounding Centers Of America Oral Transmucosal Compositions including Aromatase Inhibitors for Low Testosterone Levels in Men
US10525099B2 (en) 2014-10-01 2020-01-07 Oxytone Bioscience B.V. Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance
HUE051974T2 (hu) 2014-10-01 2021-04-28 Oxytone Bioscience B V Szájban szétesõ, szülést szabályozó ágenst tartalmazó, szilárd halmazállapotú gyógyászati dózisegység
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
EP3955918A1 (de) 2019-04-17 2022-02-23 COMPASS Pathfinder Limited Verfahren zur behandlung neurokognitiver störungen, chronischer schmerzen und verringerung von entzündung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2208120A (en) * 1938-03-02 1940-07-16 William B Coleman Pharmaceutical preparation and method of making same
US3943928A (en) * 1974-09-25 1976-03-16 Lariccia Anthony H Eliminating the safety hazard in oral dissolution of a solid
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4551329A (en) * 1984-01-20 1985-11-05 Joan Harris Oral medicament lollipop
US4671953A (en) * 1985-05-01 1987-06-09 University Of Utah Research Foundation Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155036B (da) * 1977-08-05 1989-01-30 Battelle Memorial Institute Fremgangsmaade til fremstilling af oploesninger eller suspensioner af liposomer i vandige medier.

Also Published As

Publication number Publication date
NO920854L (no) 1992-04-27
AU6069794A (en) 1994-06-23
DK30092D0 (da) 1992-03-05
EP0493380A1 (de) 1992-07-08
WO1991003233A1 (en) 1991-03-21
NO920855D0 (no) 1992-03-04
DE68928415D1 (de) 1997-12-04
EP0493380B1 (de) 1997-10-29
AU645966B2 (en) 1994-02-03
JP2758985B2 (ja) 1998-05-28
ATE159658T1 (de) 1997-11-15
DE68928415T2 (de) 1998-02-26
EP0493380A4 (en) 1992-10-07
NO920855L (no) 1992-04-10
DK30092A (da) 1992-05-05
NO920854D0 (no) 1992-03-04
AU5035290A (en) 1991-04-08
JPH05501854A (ja) 1993-04-08

Similar Documents

Publication Publication Date Title
US4671953A (en) Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
US4885173A (en) Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US6358060B2 (en) Two-stage transmucosal medicine delivery system for symptom relief
KR100679767B1 (ko) 신규의 치환 벤즈이미다졸 투약형 및 이의 용법
CN102770138B (zh) 含有尼古丁的软凝胶锭剂
US11642312B2 (en) Blend compositions for oral administration as a rapidly dissolving powder and/or suspension
DK175773B1 (da) Fremgangsmåde og midler til ikke-invasiv "dosis-til-virkning" administration af lipofile lægemidler
US6103257A (en) System for delivering pharmaceuticals to the buccal mucosa
WO2012035541A1 (en) Nicotine containing formulation
US9226944B2 (en) Herbal preparation for sleep apnea relief
CA1339075C (en) Methods and compositions for noninvasive dose-to-effect administration of lipophilic drugs
AU684888B2 (en) Method and compositions for noninvasive dose to effect administration of lipophilic drugs
CA1339080C (en) Methods and compositions for noninvasive dose-to-effect adminsitration of drugs with cardiovascular or renal vascular acitivities
Chauhan et al. Nicotine replacement therapy for smoking cessation
CN111773176A (zh) 一种加味糖块型含化口腔粘膜表面麻醉药
Hoyt Practical Therapeutics: Including Materia Medica and Prescription Writing, with a Description of the Most Important New and Nonofficial Remedies Passed Upon by the Council on Pharmacy and Chemistry of the American Medical Association
Hoyt Practical therapeutics, including materia medica and prescription writing
Muirhead et al. A textbook of materia medica for nurses

Legal Events

Date Code Title Description
PUP Patent expired